Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
Authors
Keywords
-
Journal
Life-Basel
Volume 13, Issue 11, Pages 2170
Publisher
MDPI AG
Online
2023-11-06
DOI
10.3390/life13112170
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2023) Robin Kate Kelley et al. LANCET
- British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma
- (2023) Simon M Rushbrook et al. GUT
- A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1.
- (2022) Do-Youn Oh et al. JOURNAL OF CLINICAL ONCOLOGY
- 56P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)
- (2022) D-Y. Oh et al. ANNALS OF ONCOLOGY
- Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- (2022) A. Vogel et al. ANNALS OF ONCOLOGY
- Second-line chemotherapy (2L) in elderly patients with advanced biliary tract cancer (ABC): A multicenter real-world study.
- (2021) Alessandro Rizzo et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted therapies for gallbladder cancer: an overview of agents in preclinical and clinical development
- (2021) Stefania De Lorenzo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial
- (2021) Angela Lamarca et al. LANCET ONCOLOGY
- Liposomal irinotecan plus fluorouracil and leucovorin versus fluorouracil and leucovorin for metastatic biliary tract cancer after progression on gemcitabine plus cisplatin (NIFTY): a multicentre, open-label, randomised, phase 2b study
- (2021) Changhoon Yoo et al. LANCET ONCOLOGY
- Pattern of progression of intrahepatic cholangiocarcinoma: Implications for second‐line clinical trials
- (2021) Francesco Tovoli et al. LIVER INTERNATIONAL
- Intrahepatic Cholangiocarcinoma: A Summative Review of Biomarkers and Targeted Therapies
- (2021) Alexandra W. Acher et al. Cancers
- Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
- (2020) Ghassan K Abou-Alfa et al. LANCET ONCOLOGY
- Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
- (2020) Ghassan K Abou-Alfa et al. LANCET ONCOLOGY
- Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer
- (2020) Cindy Neuzillet et al. INTERNATIONAL JOURNAL OF CANCER
- Larotrectinib in adult patients with solid tumours: a multicentre, open-label, phase I dose-escalation study
- (2019) D S Hong et al. ANNALS OF ONCOLOGY
- Combination versus mono-therapy as second-line treatment for advanced biliary tract cancer: a systematic review and meta-analysis of published data
- (2019) Jie Ying et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Medical treatment for cholangiocarcinoma
- (2019) Jorge Adeva et al. LIVER INTERNATIONAL
- Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations
- (2019) Cindy Neuzillet et al. EUROPEAN JOURNAL OF CANCER
- Second‐line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes
- (2019) Maeve A. Lowery et al. CANCER
- Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
- (2019) Robert C Doebele et al. LANCET ONCOLOGY
- LBA28Updated results from a phase II study of infigratinib (BGJ398), a selective pan-FGFR kinase inhibitor, in patients with previously treated advanced cholangiocarcinoma containing FGFR2 fusions
- (2018) M Javle et al. ANNALS OF ONCOLOGY
- Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
- (2017) Apinya Jusakul et al. Cancer Discovery
- Second-line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine-platinum combination: A large multicenter study by the Association des Gastro-Entérologues Oncologues
- (2015) Bertrand Brieau et al. CANCER
- Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data
- (2015) Lorenzo Fornaro et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Second-line chemotherapy in advanced biliary cancer: a systematic review
- (2014) A. Lamarca et al. ANNALS OF ONCOLOGY
- Outcome of second-line chemotherapy for biliary tract cancer
- (2012) John Bridgewater et al. EUROPEAN JOURNAL OF CANCER
- Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study
- (2012) Thomas Walter et al. EUROPEAN JOURNAL OF CANCER
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intrahepatic Cholangiocarcinoma
- (2009) Itaru Endo et al. ANNALS OF SURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now